FDA
approval
· 2022-07-19
FDA Approved: AKLIEF — Supplemental Application (Galderma Laboratories, L.P.)
Summary
This FDA document concerns a supplemental application for AKLIEF (trifarotene) submitted by Galderma Laboratories, L.P.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AKLIEF (TRIFAROTENE)